Investigation Effectiveness Drives Human Performance Excellence
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2016
Volume 2016 eBook
Issue 3
Pages: s38–s47
Are investigations supporting or hindering performance excellence?
Every biopharm company conducts investigations for undesirable outcomes related to safety, quality, and reliability of product and processes. The question is to what degree do these investigations support or hinder performance excellence?
A sub-team that was formed as part of the BioPhorum Operations Group (BPOG) human performance workstream sought to answer this question. The findings suggest that biopharm is behind other industries with respect to investigation best practices.
This article provides a pathway for the industry to improve its investigations, and in so doing, improve overall organizational learning and performance.
Download Pharmaceutical Technology’s
2016 Quality Throughout the Supply Chain eBook.
Articles in this issue
Extending QMS to Contract Partners
Too Much by Half: Misapplication of the Half-Cycle Approach to Sterilization
Investigation Effectiveness Drives Human Performance Excellence
Is Global Regulatory Gridlock Slowing Modernization?
Paperless Batch Records for the Masses
Could Greater Transparency Improve Pharmaceutical Quality and Compliance?
Ensuring Quality in Pharmaceutical Raw Materials
Microbiological Testing: Time is of the Essence
Recent Videos
Related Content
